BioDlink International Company Limited (HKG:1875)
3.230
-0.060 (-1.82%)
Jun 18, 2026, 11:28 AM HKT
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 2.54 billion as of June 17, 2026. Its market cap has increased by 82.78% in one year.
Market Cap
2.54B
Enterprise Value
2.60B
Revenue
831.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.23
Market Cap Chart
Since November 8, 2019, HKG:1875's market cap has decreased from 3.57B to 2.54B, a decrease of -28.75%. That is a compound annual growth rate of -5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.54B | 31.60% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.45B |
| Qyuns Therapeutics | 3.41B |
| Jiangsu Recbio Technology | 2.97B |
| Shandong Boan Biotechnology | 2.91B |
| PegBio | 2.51B |
| TYK Medicines | 2.48B |
| Viva Biotech Holdings | 2.39B |
| Beijing Luzhu Biotechnology | 2.39B |